Background: Timing of surgery remains a controversial subject with some concerns persisting that the benefit of early carotid endarterectomy (CEA) offsets the perioperative risks. We investigated the neurological outcome of patients with symptomatic internal carotid artery (ICA) stenosis after surgery in relation to the timing of treatment. Methods: From January 2005 to June 2010, 468 patients (n Z 349 male, 74.6%, median age 71 years) underwent CEA for symptomatic stenosis. Perioperative morbidity and mortality rates were assessed in the 30 days' follow-up. Results: The median time interval between index event and CEA was 7 days; the overall stroke and death rate reached 3.4%. There was no difference in the 30 days' rate of stroke /death rate, depending on the timing of surgery (n Z 5/241, 2.1% in patients treated within 1 week vs. n Z 10/215, 4.7% in patients treated thereafter, p Z 0.12). Patients with a postoperative neurological deterioration had more often an ischaemic infarction on preoperative cerebral computed tomography (CCT) compared with those without deterioration (n Z 6/15, 40.0% vs. n Z 39/441, 9.0%, p Z 0.003). Logistic regression analysis showed that patients with preoperative infarction on CCT had the highest risk for postoperative neurological deterioration. Conclusion: An infarction on the preoperative CCT leads to an increased risk for a postoperative deterioration after CEA. Patients should be treated at an early point in time with bland CCTs. ª
Carotid endarterectomy (CEA) still represents the gold standard in the treatment of symptomatic carotid artery stenosis, given a perioperative stroke and death rate of <6%. It is widely accepted that CEA is most beneficial if it is performed within 2 weeks of the index symptom and many professional societies have changed their guidelines regarding this new timeframe. 1e4 However, there is still evidence of significant delays within national audits. Halliday et al. reported that in the UK, only 20% of symptomatic patients had surgery within the targeted 2 weeks. 5 Any delay is associated with an increased risk of a second disabling or fatal stroke in the waiting period. There are various factors identifying patients at high risk for a recurrent ischaemic event. 6 Morphological factors, such as plaque surface and ischaemic area in the cerebral computed tomography (CCT), as well as gender, age and contralateral pathology have an influence on the course and risk of recurrence of ischaemic events after an ischaemic index event. 7e10 The aims of the article at hand were two issues.
(1) What is the neurological outcome of patients treated early by CEA after the index event? (2) Which risk factors are associated with postoperative neurological deterioration after early CEA?
Methods

Patient selection
We evaluated the data of all patients consecutively treated for a symptomatic carotid artery stenosis between January 2005 and June 2010. Patients with a severe stenosis of at least 50% of the internal carotid artery and symptoms (transient ischaemic attacks (TIAs), amaurosis fugax and stroke) that originated from the carotid artery stenosis within the last 6 months were included in the data analysis. Five patients who had symptoms more than 6 months prior to the surgery were excluded. In four patients with bilateral symptomatic stenosis and separate treatment on the two sides, we randomly chose sides for statistical analysis. Another three patients who were allocated from another hospital were excluded from analysis because of incomplete data about the time point and the character of the ischaemic event.
Baseline investigation
Demographic and morphological data were assessed from all patients. The patients were admitted to a stroke unit and neurological status was available for all patients at admission. Neurological symptoms were classified as TIA, amaurosis fugax and stroke. In addition, neurological function and severity of impairment was measured using the modified Rankin scale. The Rankin classification was applied for all patients by a single experienced neurologist. All patients had ultrasound scanning for the calculation of the degree of carotid artery stenosis, according to Grey Scale and Doppler US Criteria for Diagnosis of ICA Stenosis. 11 In addition, cerebral diagnostics was performed either by CCT with a contrast medium or by magnetic resonance imaging (MRI), depending on the renal function. The aims of neuroimaging were (1) to rule out haemorrhage, (2) to demonstrate the presence of ischaemia and (3) to show the presence of haemodynamically compromised tissue as tissue at risk or penumbra. We classified CCT findings into five groups according to the state and severity of ischaemia: (1) no ischaemia, (2) old infarction: scar, decreased attenuation due to missing perfusion, (3) oedema: earliest stage of brain damage with decreased perifocal attenuation, (4) leaking bloodebrain barrier: diffuse accumulation of contrast medium indicating the loss of integrity of the bloodebrain barrier and (5) recent infarction: defined area with decreased cerebral blood flow. Vascular autoregulation is the mechanism by which regional cerebral blood flow is maintained. In case of cerebral ischaemia, the perfusion pressure is decreased, which results in a prolongation of the blood transit time in both areas, the ischaemic core and the penumbra. In the penumbral tissue and not in the infarct core, the process of autoregulation induces dilation of capillaries with an attempt to maintain a constant blood flow. However, in the infarct core, autoregulation mechanisms are overwhelmed and the blood flow diminishes. 12 CT scans were routinely done at admission. In case of postponed surgery, cerebral diagnostics was repeated the night before surgery. The latest CCT scan was used for the statistical risk analysis. All CCTs were assessed by a single experienced radiologist, and the size of infarction was measured. In case of MRI diagnostics, patients were excluded from the study because of varying sensitivity and specificity to detect a cerebral ischaemia compared with a CCT. The final decision towards surgery and the timing of surgery was made in an interdisciplinary conference between neurologists, interventional radiologists and vascular surgeons, considering the severity of the clinical neurological deficit and the stage of brain damage in the CCT of the patient.
Six surgeons performed CEAs during the study period. All CEAs were carried out under general anaesthesia. Heparin (5000 IU) was administered intravenously before cross clamping. Anti-platelet therapy was not stopped perioperatively. Intra-operative angiography was routinely done, except in patients with severe renal function impairment.
Postoperative investigations
Matters of interest in the 30-day follow-up period were ipsiand contralateral ischaemic events, myocardial infarction and death from any cause. On the 2nd or 3rd postoperative day, an ultrasound scanning of the internal carotid artery and a neurological status of the patients were performed. If the patients showed new neurological symptoms, the neurological examination was repeated at once. Patients with hyperperfusion were kept as inpatients for at least 7 days, with repeated ultrasound investigation and tight control of the blood pressure.
A periprocedural stroke was clinically defined as an increase on the Rankin scale of at least 1 point. In case of a neurological deterioration or varying neurological symptoms, the cerebral imaging was repeated.
Statistical analysis
Comparisons of variables were performed using nonparametric Wilcoxon rank sum tests, and Pearson's c 2 -test was appropriate. Variables contributing to the final neurological complication status were identified by multiple logistic regression analysis.
Statistical analyses were performed with the Statistical Package for Social Sciences for Windows (SPSS, Chicago, IL, USA) version 18.0.
Results
A total of 468 patients (n Z 349 male, 74.6%, median age 71 years) underwent CEA during the observation period for neurological symptoms. All CEAs were primary and originated from atherosclerotic plaques. The majority of patients showed up with TIAs and amaurosis fugax (n Z 302, 64.5%), the severity of functional impairment (measured by the modified Rankin scale) was according to that (modified Rankins scale 2: n Z 424, 90.6%). The mean delay between latest CCT, used for analysis, and treatment was 2.5 days; the median interval was 1 day in the overall study population. The overall perioperative 30 days' stroke and death rate among patients was 3.4% (n Z 15 second ischaemic events, one death). One patient with an initial TIA, who was treated 2 days after the onset of symptoms, died on postoperative day 10 due to an intracerebral haemorrhage after hyperperfusion syndrome. We did not find any myocardial infarction among our study population, and no contralateral cerebral ischaemic events were observed. CCT findings in patients with postoperative neurological deterioration were as follows: in four cases (26.7%), we saw a haemorrhage in the postoperative CCT, nine patients (60%) experienced an ischaemic infarction. Two patients (13.3%) remained without new cerebral lesions in the CCT despite new neurological symptoms. We observed one asymptomatic new infarction in a patient where CCT was repeated because of suspected intracranial vessel stenosis. The median delay between index event and surgery was 7 days in the overall study population. After dividing patients according to the neurological index event (TIA, amaurosis fugax and stroke), we saw that the median interval of onset of symptoms and treatment did not extremely differ in these groups (Fig. 1 ). To keep statistical power, we used the overall median delay as cut-off value for further analyses. Table 1a summarises patient characteristics divided into two time groups and shows that patients with strokes and conformable Rankin scores were predominantly treated more than 1 week after the index event. In accordance with that, we saw that patients treated in the later time period demonstrated pathological findings more frequently in the CCT. In case of preoperative cerebral infarction, lesion size was larger in the delayed treatment group (13.0 vs. 24.1 mm, p Z 0.002). Morphological and technical data were comparable between the two groups.
Neurological outcome of patients treated rapidly after the index event
There was no significant difference in postoperative stroke rates in the early compared with the delayed group (Table  1b ). The early treatment group even showed a lower rate of perioperative complications (n Z 5/241, 2.1% in the early treatment group vs. n Z 10/215, 4.7% in the delayed group, p Z 0.12).
Risk factors for a postoperative neurological deterioration after early CEA
There was no significant difference in the mode of presentation between patients who experienced a postoperative deterioration and those without worsening ( Table 2) . We saw a statistically significant difference, however, concerning pathological findings in the CCTs (summed up in three groups) in patients with periprocedural neurological deterioration compared with those without deterioration ( Table 2 ). Size of preoperative infarction was comparable in both groups ( Table 2) . Table 3a shows the association of the clinical neurological deficit assessed by the Rankin scale and the morphological brain damage in the CCT before treatment. Table 3b additionally shows the association between CCT findings and the character of the qualifying neurological event at admission. This showed that at least 3.3% of patients with a mild neurological defect (TIA and amaurosis fugax) already showed signs of a cerebral infarction in the CT diagnostics.
Age, gender, American Society of Anesthesiologists (ASA) score, timing of surgery and CCT findings before surgery were considered as most important factors contributing to the neurological course of patients. The multiple logistic regression analysis was accordingly adjusted and showed that the CCT before surgery was the strongest predictor of the postoperative outcome. In a first step, we performed the regression analysis with CCT findings (divided in five groups) as continuous parameter, according to the state of ischaemia. The odds ratio for suffering a neurological deterioration was 1.71 (95% confidence interval (CI) 1.26e2.31, p Z 0.001) for each state of ischaemia (Table 4a ). Thereafter, we summed up the early stages of brain damage (oedema and leaking bloodebrain barrier) and compared it with the situation of a recent infarction. We saw a significant difference in this model. Signs of an infarction increased the probability for a neurological deterioration 7.6 fold. Surgery was not risky in the early stages of brain damage, however (Table 4b ). Timing of surgery and the co-morbidities of the patients (measured by the ASA classification) did not influence the outcome in either model (Tables 4a and 4b ).
Discussion
Our study revealed that early surgery after an ischaemic index event is safe and effective in stroke therapy. It seems that a severe clinical neurological deficit does not contraindicate early treatment. In case of a recent infarction in the CCT, surgery should be postponed, however. 
Neurological outcome of patients treated rapidly after the index event
A reanalysis of the pooled data of the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the European Carotid Surgery Trial (ECST) revealed that surgery was most effective after an ischaemic stroke in patients who were treated within the first 2 weeks, with a rapid decline of the benefit thereafter, especially in women. 13, 14 The diminishing benefit originates from the early risk of a recurrent ischaemic event after the index event, in particular after a TIA or a minor stroke. The 30day risk of a re-stroke is four to six times higher than initially reported in literature, with the highest risk in the first 7 days. 15 Rothwell et al. report in their review of 2416 patients with ischaemic stroke that one-quarter of patients experienced a preceding TIA. About 17% of those TIAs occurred on the same day, 9% occurred on the day before the stroke and 43% of overall TIAs happened within 1 week before stroke onset. 16 In a recently published series, Ois and colleagues present data of a neurologic recurrence of 20.9% within 72 h, 6.7% for the first week and 3.7% for the second week. 17 In our study population, we did not find recurrent ischaemic events in patients awaiting surgery. Several studies have recently demonstrated the safety of performing CEA at an early point in time after the start of neurological symptoms. The perioperative morbidity and mortality rates are comparable with those for delayed surgery in otherwise stable patients. 18e25 Naylor has suggested that early CEA prevents more strokes than the delayed surgery, even with higher perioperative stroke rates than would normally be accepted. 26 Salem and co-workers recently published data of 108 consecutive patients with symptomatic internal carotid artery stenosis focussing on the 30-day outcomes. They saw a perioperative 30-day death/ stroke rate of 2.4% in patients treated within 14 days of the index event, increasing to 4.3% in patients undergoing surgery within 7 days. The authors conclude from their data that, in the hyperacute phase, CEA can safely be performed without significantly increasing the perioperative risk. 27 We could confirm this with the data at hand. Treatment within the first 7 days after the index ischaemic event showed good perioperative outcomes for the patients in our study population.
Risk factors for a postoperative neurological deterioration after early CEA
Amongst several single-centre observations, Paty et al. presented a retrospective series of 228 patients with CEA performed within 1e4 weeks after an ischaemic stroke. The reported permanent perioperative neurological deficit ranged between 2.8% and 3.4% equally among the four time groups (1e4 weeks). 28 With the data at hand, we confirmed our own data from a publication in 2006 where we already observed that the perioperative neurological outcome did not depend on the timing of surgery. 23 Bond published a systematic review in 4278 patients with minor stroke who had CEA, either early (<3e6 weeks) or delayed (>3e6 weeks). This review showed no higher risk of stroke with early treatment in stable patients. The authors found no increased risk for surgery after stroke versus cerebral TIA in 23 studies. 29 These results are in agreement with data from Capoccia et al., who report in their retrospective series of 62 patients that a severe neurological deficit (measured using the National Institutes of Health Stroke Scale (NIHSS) score) does not contraindicate early surgery. 30 The initial neurological deficit did also not influence the further course of the patients in our study population. The risk of haemorrhagic transformation of the ischaemic area after a stroke is a matter of major concern in stroke therapy. The rate of conversion might be reassuringly low in literature, however. 15, 26 Our data indicate that the risk of an intracranial haemorrhage or cerebral re-infarction with an impairment of the neurological function is highest in patients with pre-existing morphological signs of cerebral infarctions. We found a significant increase for a neurological deterioration of at least one point on the Rankin scale in case of a cerebral infarction before surgery in the CCT. Early signs of cerebral damage (oedema) in the CCT and even a leaking bloodebrain barrier were not hazardous for surgery. Paty et al. described similar results in their study. Moreover, they described that an increasing lesion size on the preoperative CCT scan increased the odds of a permanent neurological deficit by 1.7 (95% CI 1.1e2.8, p Z 0.03) per centimetre of diameter. 28 The lesion size was of no relevance in our investigation, certainly due to the small number of patients. Other factors, such as the number of comorbidities, measured by the ASA classification, or the timing of surgery, were not contributing to a perioperative neurological deterioration.
In clinical practice, CCT scanning is not consistently performed in patients with TIA or amaurosis fugax. Our data show that clinical symptoms do not strongly correlate with the morphological findings in the CCT (Tables 3a and 3b) : 64% of our patients with clinical strokes had bland CCTs; on the other hand, 3.3% of patients presenting with TIAs or an episode of amaurosis fugax already had signs of an infarction in the CCT before surgery. This implicates to perform cerebral diagnostics in any case, even if patients show up with moderate neurological symptoms.
The main limitation of this study is the retrospective design. Complete data collection was not possible, as patients were also allocated from other hospitals. Besides that, we had little numbers of perioperative complications. This restricted statistical analysis. It might have been reasonable to divide the study population into two groups, according to the qualifying neurological event (TIA and amaurosis fugax vs. stroke), to appropriately picture the severity of the disease. However, with a total of 15 perioperative neurological events we lose power for calculations in the subgroups. We conclude from the data at hand that further studies are necessary to define best treatment strategies for patients with recent infarction in the CCT. The fact that ischaemic events predominantly recur within the first 7e14 days after a qualifying index event makes the decision to postpone surgery extremely difficult. The benefit of early treatment needs to be weighed with the risk of a postoperative intracerebral haemorrhage in these patients in a larger cohort. This is, to our knowledge, the largest single-centre series from patients with symptomatic carotid artery stenosis and early treatment within 1 week after the index event. Our data support the concept of early CEA in the daily routine. CEA can safely be performed in the majority of patients. It should be discussed, however, to postpone surgery in patients with severe morphological defects as signs of acute infarction in the neuroimaging, or even better, treat patients at an early point in time without relevant cerebral lesions.
